Damage to important clinical trials by over-regulation-Reference-Cited by-同舟云学术

Damage to important clinical trials by over-regulation

Published:2010-12 Issue:6 Volume:7 Page:622-625
ISSN:1740-7745
Container-title:Clinical Trials
language:en
Short-container-title:Clinical Trials

Author:

Yusuf Salim¹

Affiliation:

1. Department of Medicine, and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada, Faculty of Health Sciences, Hamilton Health Sciences, Hamilton, Ontario, Canada, Heart and Stroke Foundation of Ontario/Marion W. Burke Chair in Cardiovascular Disease, McMaster University, Hamilton, Ontario, Canada,

Publisher

SAGE Publications

Subject

Pharmacology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1740774510387850

Reference6 articles.

1. Randomized clinical trials: Slow death by a thousand unnecessary policies?

2. Specific barriers to the conduct of randomized trials

3. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health

4. Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases

5. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable or Biodegradable Polymer Stent Coatings;Circulation;2021-03-16

2. Between Participation and Capture in International Rule-Making: The WHO Framework of Engagement with Non-State Actors;European Journal of International Law;2021-02-01

3. An investigation into the factors affecting investigator-initiated trial start-up in Ireland;Trials;2020-11-23

4. Between Participation and Capture in International Rule-Making: The WHO Framework of Engagement with Non-State Actors;SSRN Electronic Journal;2020

5. Accordion Governance;ICL Journal;2019-10-01